Home/ Supplements/ Electrolytes/ Promensil Menopause Double Strength

Promensil Menopause Double Strength

product on market Tablet or Pill Real Health Laboratories Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Promensil Menopause Double Strength
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
30
Servings
Other Combinations
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calcium
50 mg (5% DV)
standardized Red Clover extract
200 mg

Other Ingredients

Calcium Phosphate Microcrystalline Cellulose Coating Solution Silica Croscarmellose Sodium Magnesium Stearate Mixed Tocopherols Carnauba wax
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

30 tablets one per day

Directions: Take one tablet per day with food. While individual results will vary, most will notice a difference within 6-8 weeks.

Warnings & Precautions

Please consult with your primary care provider prior use if you have or suspect a medical condition, are taking prescription drugs, or prescription drugs, or are pregnant or lactating.

People with allergies to soy should consult their healthcare provider before taking this product.

Formulation Notes

Safe & Natural relief from the symptoms of menopause Clinically tested formula shown to help relieve: Hot flashes Night sweats throughout menopause

80 mg optimum level red clover isoflavones

Promensil has been clinically tested to help: Reduce frequency and severity of hot flashes Reduce severity of night sweats Maintain a healthy cardiovascular system

Promensil also works to help support: Breast health Heart health Emotional well being Hormone balance Bone health Improved libido

Breast health Hormone balance

Additional Information

1 month supply

Lipovac, et al (2010), Gynecological Endocrinology, 2011, 1-5

Metadata

Product Details

DSLD Entry Date2021-07-27
Product TypeOther Combinations
FormTablet or Pill
DSLD ID245007
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.